Cargando…

The Development, Application and Analysis of an Enhanced Recovery Programme for Major Oesophagogastric Resection

BACKGROUND: Enhanced recovery programmes improve outcomes in surgery, but their implementation after upper gastrointestinal resection has been limited. The aim of this study was to compare short-term outcomes for patients undergoing oesophagogastric surgery in an enhanced recovery programme (EROS)....

Descripción completa

Detalles Bibliográficos
Autores principales:	Underwood, Timothy J., Noble, F., Madhusudan, N., Sharland, D., Fraser, R., Owsley, J., Grant, M., Kelly, J. J., Byrne, James P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359364/ https://www.ncbi.nlm.nih.gov/pubmed/28120276 http://dx.doi.org/10.1007/s11605-017-3363-8

Ejemplares similares

Author response to: Impact of postoperative chemotherapy on survival for oesophagogastric adenocarcinoma after preoperative chemotherapy and surgery
por: Rahman, Saqib A, et al.
Publicado: (2022)

Resection of oesophageal and oesophagogastric junction cancer liver metastases — a summary of current evidence
por: Weiss, Andreas R. R., et al.
Publicado: (2021)

Impact of postoperative chemotherapy on survival for oesophagogastric adenocarcinoma after preoperative chemotherapy and surgery
por: Rahman, Saqib, et al.
Publicado: (2021)

Outcomes following Oesophagogastric Resections during COVID-19: A Comparative Analysis
por: Nnaji, Martin, et al.
Publicado: (2021)

Multicentre cohort study to define and validate pathological assessment of response to neoadjuvant therapy in oesophagogastric adenocarcinoma
por: Noble, F, et al.
Publicado: (2017)

Assessment of the Burden of Small Intestinal Bacterial Overgrowth (SIBO) in Patients After Oesophagogastric (OG) Cancer Resection
por: Savva, K.-V., et al.
Publicado: (2021)

The prognostic impact of pre-treatment cachexia in resectional surgery for oesophagogastric cancer: a meta-analysis and meta-regression
por: Brown, Leo R, et al.
Publicado: (2023)

The evolving immunotherapeutic landscape in advanced oesophagogastric cancer
por: Flynn, Michael, et al.
Publicado: (2018)

Perioperative Therapy of Oesophagogastric Adenocarcinoma: Mainstay and Future Directions
por: Bose, Katrin, et al.
Publicado: (2017)

Endoluminal Vacuum Therapy (E-Vac): A Treatment Option in Oesophagogastric Surgery
por: Pournaras, D. J., et al.
Publicado: (2018)

Prognostic value of histopathological regression in 850 neoadjuvantly treated oesophagogastric adenocarcinomas
por: Schmidt, T, et al.
Publicado: (2014)

Effectiveness of additional antireflux surgery after resection of oesophagogastric junction cancer: protocol for a systematic review and meta-analysis
por: Wang, Na, et al.
Publicado: (2022)

Laparoscopic fundoplication and new aspects of neural anatomy at the oesophagogastric junction
por: Gehwolf, P., et al.
Publicado: (2020)

Laparoscopic vs. open feeding jejunostomy insertion in oesophagogastric cancer
por: Mastoridis, Sotiris, et al.
Publicado: (2021)

A feasibility trial of prehabilitation before oesophagogastric cancer surgery using a multi-component home-based exercise programme: the ChemoFit study
por: Chmelo, Jakub, et al.
Publicado: (2022)

Panitumumab added to docetaxel, cisplatin and fluoropyrimidine in oesophagogastric cancer: ATTAX3 phase II trial
por: Tebbutt, Niall C, et al.
Publicado: (2016)

Value of individual surgeon performance metrics as quality assurance measures in oesophagogastric cancer surgery
por: Powell, A. G. M. T., et al.
Publicado: (2019)

Early application of haemostatic powder added to standard management for oesophagogastric variceal bleeding: a randomised trial
por: Ibrahim, Mostafa, et al.
Publicado: (2019)

The relevance of the Siewert classification in the era of multimodal therapy for adenocarcinoma of the gastro-oesophageal junction
por: Curtis, Nathan J, et al.
Publicado: (2014)

Cardiopulmonary exercise testing as a predictor of complications in oesophagogastric cancer surgery
por: Moyes, LH, et al.
Publicado: (2013)

Assessment of a Noninvasive Exhaled Breath Test for the Diagnosis of Oesophagogastric Cancer
por: Markar, Sheraz R., et al.
Publicado: (2018)

The Effect of COVID-19 on Multidisciplinary Team (MDT) Outcomes for Oesophagogastric Cancer
por: Matias, Nadia, et al.
Publicado: (2023)

Role of mobile applications for the success of enhanced recovery after surgery programme
por: Nair, Abhijit, et al.
Publicado: (2021)

Perioperative rifaximin is not associated with enhanced functional and volumetric recovery after major liver resection
por: Bednarsch, Jan, et al.
Publicado: (2021)

Development of an alarm symptom-based risk prediction score for localized oesophagogastric adenocarcinoma (VIOLA score)
por: Puhr, H.C., et al.
Publicado: (2022)

The effect of the enhanced recovery programme on long-term survival following liver resection for colorectal liver metastases
por: Lambert, Joel, et al.
Publicado: (2023)

Early recognition of anorexia through patient-generated assessment predicts survival in patients with oesophagogastric cancer
por: Abraham, Marc, et al.
Publicado: (2019)

ELEVATE – evaluating Temozolomide and Nivolumab in patients with advanced unresectable previously treated oesophagogastric adenocarcinoma with MGMT methylation: study protocol for a single arm phase II trial
por: Smyth, Elizabeth, et al.
Publicado: (2022)

Effect of perioperative FLOT versus ECF/ECX on short-term outcomes after surgery for resectable oesophagogastric adenocarcinoma: propensity score-matched study
por: Moussa, Osama, et al.
Publicado: (2022)

Trends and variation in the management of oesophagogastric cancer patients: a population-based survey
por: Lyratzopoulos, Georgios, et al.
Publicado: (2009)

The role of the Shuttle Walking Test in predicting mortality and morbidity post oesophagogastric surgery
por: Whiting, P, et al.
Publicado: (2005)

Failure to rescue patients from early critical complications of oesophagogastric cancer surgery
por: Weledji, Elroy P., et al.
Publicado: (2016)

Prognostic Relevance of Weight and Weight Loss during Multimodal Therapy for Oesophagogastric Tumours
por: Lorusso, Alessandro, et al.
Publicado: (2022)

Dose-escalated neoadjuvant chemoradiotherapy for locally advanced oesophageal or oesophagogastric junctional adenocarcinoma
por: Duque-Santana, Victor, et al.
Publicado: (2022)

Evaluation of the Oesophagogastric Cancer-Associated Microbiome: A Systematic Review and Quality Assessment
por: Vadhwana, Bhamini, et al.
Publicado: (2023)

Real-World Outcomes of FLOT versus CROSS Regimens for Patients with Oesophagogastric Cancers
por: Shahnam, Adel, et al.
Publicado: (2023)

Volumetric and Functional Recovery of the Remnant Liver After Major Liver Resection with Prior Portal Vein Embolization: Recovery After PVE and Liver Resection
por: van den Esschert, Jacomina W., et al.
Publicado: (2009)

Diagnosis, treatment, and outcome of patients with oesophagogastric cancer during the COVID-19 pandemic: national study
por: Baxter, Mark A, et al.
Publicado: (2023)

Opposing Immune-Metabolic Signature in Visceral Versus Subcutaneous Adipose Tissue in Patients with Adenocarcinoma of the Oesophagus and the Oesophagogastric Junction
por: Heeran, Aisling B., et al.
Publicado: (2021)

Phase I study of epirubicin, cisplatin and capecitabine plus matuzumab in previously untreated patients with advanced oesophagogastric cancer
por: Rao, S, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_8cs2an6hdg35e2802vd0m3m5vq